• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Oct 7;15(1):8574.
doi: 10.1038/s41467-024-52808-2. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1

Hisano Yajima[SUP] 1 [/SUP], Yuki Anraku[SUP] 2 [/SUP], Yu Kaku[SUP] 3 [/SUP], Kanako Terakado Kimura[SUP] 1 [/SUP], Arnon Plianchaisuk[SUP] 3 [/SUP], Kaho Okumura[SUP] 3 4 [/SUP], Yoshiko Nakada-Nakura[SUP] 1 [/SUP], Yusuke Atarashi[SUP] 1 5 [/SUP], Takuya Hemmi[SUP] 1 [/SUP], Daisuke Kuroda[SUP] 5 [/SUP], Yoshimasa Takahashi[SUP] 5 6 [/SUP], Shunsuke Kita[SUP] 2 [/SUP], Jiei Sasaki[SUP] 1 [/SUP], Hiromi Sumita[SUP] 7 [/SUP]; Genotype to Phenotype Japan (G2P-Japan) Consortium; Jumpei Ito[SUP] 3 8 [/SUP], Katsumi Maenaka[SUP] 2 6 9 10 11 [/SUP], Kei Sato[SUP] 12 13 14 15 16 17 18 19 [/SUP], Takao Hashiguchi[SUP] 20 21 22 [/SUP]



Collaborators, Affiliations
Abstract

Since 2019, SARS-CoV-2 has undergone mutations, resulting in pandemic and epidemic waves. The SARS-CoV-2 spike protein, crucial for cellular entry, binds to the ACE2 receptor exclusively when its receptor-binding domain (RBD) adopts the up-conformation. However, whether ACE2 also interacts with the RBD in the down-conformation to facilitate the conformational shift to RBD-up remains unclear. Herein, we present the structures of the BA.2.86 and the JN.1 spike proteins bound to ACE2. Notably, we successfully observed the ACE2-bound down-RBD, indicating an intermediate structure before the RBD-up conformation. The wider and mobile angle of RBDs in the up-state provides space for ACE2 to interact with the down-RBD, facilitating the transition to the RBD-up state. The K356T, but not N354-linked glycan, contributes to both of infectivity and neutralizing-antibody evasion in BA.2.86. These structural insights the spike-protein dynamics would help understand the mechanisms underlying SARS-CoV-2 infection and its neutralization.


 
Back
Top Bottom